Lithium Carbonate Tablet, Extended Release
Product Images NDC 0054-0021

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Lithium Carbonate (NDC 0054-0021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fpl-bl-300mg-100tab-05.jpg (Fpl Bl 300mg 100tab 05)

This is the label of Lithium Carbonate Extended-release tablets. It contains usages instructions, dosage information, and storage conditions. The tablets come in a tight container that is child-resistant. It should be stored at room temperature and protected from moisture. The manufacturer is West-Ward Pharmaceuticals Corp. There is a warning included in the package insert, and each tablet contains 300 mg lithium carbonate USP. There is also a unique identifier NDC 0054-0021-25. The last line includes a code 10002521/05, and the other text that includes symbols cannot be identified.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.